KEY PRODUCTS
Veranova: A CDMO that manages complexity with confidence.
01 1Veranova
01 1LISDEXAMFETAMINE DIMESYLATE
01 1U.S.A
01 1Active
01 1Complete
Veranova: A CDMO that manages complexity with confidence.
GDUFA
DMF Review : Complete
Rev. Date : 2020-01-28
Pay. Date : 2020-01-21
DMF Number : 22442
Submission : 2009-01-27
Status : Active
Type : II
20
Veranova Lp, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Veranova: A CDMO that manages complexity with confidence.
One of their notable products is LISDEXAMFETAMINE DIMESYLATE, with a corresponding US DMF Number 22442.
Remarkably, this DMF maintains an Active status since its submission on January 27, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 28, 2020, and payment made on January 21, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II
